Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Miromatrix Medical Inc (MIRO)

Miromatrix Medical Inc (MIRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates Zacks - Wed May 10, 2023

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -28.57% and 70.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 11.44 (+1.96%)
MIRO : 3.39 (+0.59%)
Arcellx, Inc. (ACLX) Reports Q1 Loss, Misses Revenue Estimates Zacks - Mon May 8, 2023

Arcellx, Inc. (ACLX) delivered earnings and revenue surprises of -123.02% and 86.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACLX : 51.97 (+2.67%)
MIRO : 3.39 (+0.59%)
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation Business Wire - Wed Apr 5, 2023

CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO) – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable...

CDNA : 14.75 (-3.22%)
MIRO : 3.39 (+0.59%)
Miromatrix Medical Inc. (MIRO) Reports Q4 Loss, Tops Revenue Estimates Zacks - Fri Mar 31, 2023

Miromatrix Medical Inc. (MIRO) delivered earnings and revenue surprises of 10.81% and 9,200%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

MIRO : 3.39 (+0.59%)
EXAS : 53.45 (-1.02%)
Lineage Cell (LCTX) Reports Q4 Loss, Misses Revenue Estimates Zacks - Thu Mar 9, 2023

Lineage Cell (LCTX) delivered earnings and revenue surprises of 0% and 35.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LCTX : 1.0900 (+4.81%)
MIRO : 3.39 (+0.59%)
Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates Zacks - Mon Mar 6, 2023

Stoke Therapeutics, Inc. (STOK) delivered earnings and revenue surprises of 9.72% and 11.42%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

STOK : 14.28 (+11.56%)
MIRO : 3.39 (+0.59%)
Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates Zacks - Tue Feb 28, 2023

Heska (HSKA) delivered earnings and revenue surprises of 44.74% and 3.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HSKA : 119.99 (+0.04%)
MIRO : 3.39 (+0.59%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Miromatrix Medical Inc. - MIRO PR Newswire - Mon Feb 6, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Miromatrix Medical Inc. ("Miromatrix" or the "Company") (NASDAQ: MIRO). Such...

MIRO : 3.39 (+0.59%)
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure Business Wire - Wed Feb 1, 2023

Miromatrix Medical Inc. (NASDAQ: MIRO) and Baxter International Inc. (NYSE:BAX) today announced a collaborative research agreement to help support additional treatment options for patients with acute liver...

MIRO : 3.39 (+0.59%)
BAX : 35.44 (+0.57%)
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer PR Newswire - Mon Jan 9, 2023

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended...

MIRO : 3.39 (+0.59%)
AXGN : 5.92 (+2.60%)
VRAY : 0.0250 (-39.90%)

Barchart Exclusives

1 Underperforming Dividend Stock With a 'Compelling' Valuation Barchart - 1 hour ago
Despite lagging behind the broader market, here’s a dividend-paying gem trading at an attractive valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot